21 July 2020: Articles
Rare diseaseRicardo Lessa de Castro A* , Neiberg de Alcantara Lima C , Danielli Oliveira da Costa Lino B , Thomas Austin Melgar A
Am J Case Rep 2020; 21:e923031
BACKGROUND: Achromobacter xylosoxidans is a ubiquitous environmental gram-negative bacterium, very resistant to antibiotics. Endocarditis caused by these bacteria is extremely rare, with only 20 cases described in the literature to our knowledge. Mortality rates are high, and treatment usually involves a combination of antibiotics and surgery. Nosocomial infections predominate with a strong association between bacteremia and immunosuppression.
CASE REPORT: A 19-year-old immunocompetent male presented with endocarditis He had interatrial and interventricular communication corrected at age 11 months and aortic coarctation correction at age 10. Initial echocardiogram showed a possible interventricular patch infection, which was later ruled out. He was treated initially for endocarditis with a combination of antibiotics, but because he remained febrile after appropriate antibiotic treatment, surgery was performed. The patient had a favorable outcome after surgery and was asymptomatic on follow-up.
CONCLUSIONS: Endocarditis caused by A. xylosoxidans is extremely rare. To date, only 20 cases of IT have been reported in the literature, of which only two involved a native valve. Given the scarcity of cases reported, there is no consensus on the best treatment.
Keywords: Achromobacter denitrificans, Endocarditis, Bacterial, Heart Valves, Adult, Aortic Valve, Child, Endocarditis, Gram-Negative Bacterial Infections, Infant, Male, young adult
Achromobacter xylosoxidans is a ubiquitous, environmental gram-negative bacterium, very resistant to antibiotics. Endocarditis caused by these bacteria is extremely rare, with only 20 cases described in the literature to our knowledge. Mortality rates are high , and treatment usually involves a combination of antibiotics and surgery. Nosocomial infections predominate with a strong association between bacteremia and immunosuppression . Here, we present a case of endocarditis caused by these uncommon bacteria in the native valve in an immunocompetent patient with no recent hospitalizations and a history of cardiac surgery, who survived after a combination of surgical and antibiotic treatment.
A 19-year-old man presented with a history of approximately 1 month of intermittent fevers, chills, dry cough, and pleuritic chest pain. He lost about 10 lb during this period and had progressive fatigue. He had a medical history of interatrial and interventricular communication corrected at 11 months of age and aortic coarctation correction at age 10.
On examination, the patient was febrile, tachycardic, and his blood pressure was 125 over 76 mmHg. Physical exam demonstrated diastolic aortic murmur, grade 3/6, compatible with aortic insufficiency. There was no jugular vein distention, the lung exam was clear, and there were no petechiae or signs of skin lesions. The rest of the patient’s physical exam was normal. Laboratory testing revealed an elevated white blood cell count of 16.45 109/L and microcytic anemia with hemoglobin of 9.1 g/dL and mean corpuscular volume of 78 fL. Creatinine was 0.71 mg/dL with a glomerular filtration rate above 60 mL/min. An HIV test done on our patient was negative. Chest x-ray showed signs of mild pulmonary congestion and an enlarged cardiac silhouette. An echocardiogram revealed a moderate left atrium enlargement and eccentric left ventricular hyper-trophy with an ejection fraction of 47%. A filamentous structure was also seen inside the patient’s left ventricle, adherent to a bicuspid aortic valve, and the ventricular patch in his inter-ventricular septum and severe aortic insufficiency. A diagnosis of endocarditis was given and the patient was placed on gentamicin, oxacillin, and ceftriaxone.
Two sets of blood cultures collected on the patient’s admission were positive for presence of Achromobacter xylosoxidans sensitive only to carbapenem with minimum inhibitory concentrations (MIC) of 0.5 and resistant to oxacillin and ceftriaxone MIC 16 for both. The antibiotics were switched but the patient continued to have fevers after 7 days of appropriate antibiotics associated with increased shortness of breath and lung congestion compatible with acute heart failure. Subsequent blood cultures performed on Day 5 of antibiotics were still positive. Because of the patient’s clinical non-response and acute-onset heart failure associated with aortic insufficiency, a surgical procedure was scheduled .
During the surgery, vegetation was seen on the patient’s aortic valve but not on his ventricular patch. Culture of the vegetation showed A xylosoxidans. The surgery was done with no major complications. He went to intensive care on moderate doses of vasopressors and was extubated 12 hours after the procedure.
On the fourth day of the patient’s hospitalization, he had a spontaneous right-sided pneumothorax, with no apparent cause, which was drained and resolved after 3 days. He went home 10 days after surgery and completed 28 days of carbapenem. His immediate and 30-day echocardiograms at follow-up did not show any vegetation. He was symptomatic at his 6-month and 1-year follow-up appointments.
Endocarditis is dangerous and difficult to treat. Prolonged fevers with weight loss in patients with a previous history of heart disease, especially after cardiac surgeries, should raise suspicion of this diagnosis.
A. xylosoxidans is an aerobic, motile, gram-negative rod that was first described in 1971 by Yabuuchi and Ohyama, who discovered it in patients with chronic, purulent otitis media . Infections with A. xylosoxidans have included meningitis, pneumonia, peritonitis, and urinary tract infections [5,6]. However, bacteremia associated with prosthetic or native valve endocarditis caused by A. xylosoxidans is rare.
A recent review published by Barragan, et al. showed that in the majority of cases, patients were immunocompromised and almost all had acquired their infections in the hospital . Reviewing our patient’s records, he had no history of recent or recurrent illnesses or hospitalizations. In most patients, infections associated with this pathogen are related to catheters [7,8] but in our report, we do not have a clear source of his infection.
To date, only 20 cases (Table 1) of A. xylosoxidans endocarditis have been reported in the literature, of which only two involved a native valve [8–28]. Considering the treatment and outcome: 11 of 19 (58%) required surgical intervention; 8 of 17 (47%) died, 2 of the 8 deaths (22%) were from the operated group and the other 6 (75%) were from the clinically treated group .
Given the scarcity of the cases reported, there is no consensus on the best treatment for A. xylosoxidans endocarditis. Antipseudomonal penicillin and carbapenems are the best choices, based on bacteriologic studies and case reports .
In contrast to use of a percutaneous atrial septal occluder device, surgical patch closure of atrial septal defects is known to represent no risk infective endocarditis . To our knowledge, only two cases of endocarditis on a surgical patch of a ventricular septal defect have been reported . Considering these previous case reports, it would be unlikely for our patient to have an infection in his patch. However, his bicuspid aortic valve increases his risk of developing endocarditis.
We presented an uncommon and rare case of A. xylosoxidans as the cause of infective endocarditis in a young, immunocompetent patient. The bacteria is very resistant and the treatment usually requires broad-spectrum antibiotics associated with surgical procedures. Our patient had a good outcome and was asymptomatic in later follow up.
1.. Xia R, Otto C, Zeng J: Cardiovasc Pathol, 2018; 36; 6-10
2.. Manfredi R, Nanetti A, Ferri M, Chiodo F: Eur J Clin Microbiol Infect Dis, 1997; 16(12); 933-38
3.. Baddour LM, Wilson WR, Bayer AS: Circulation, 2015; 132; 1435-86
4.. Ohyama A, Yabuuchi O: Jpn J Microbiol, 1971; 15(70028); 477-81
5.. Shigeta S, Yasunaga Y, Honzumi K: J Clin Pathol, 1978; 31(2); 156-61
6.. Igra-Siegman Y, Chmel H, Cobbs C: J Clin Microbiol, 1980; 11(2); 141-45
7.. Barragán EP, Pérez JS, Corbella L: Rev Esp Quimioter, 2018; 31(3); 268-73
8.. Levoy CS, Hall DJ, Berman D: JMM Case Rep, 2015; 2(6); 1-4
9.. Tea I, Caruso M, Gary P: J Am Coll Cardiol, 2019; 73(9 Suppl. 1); 2999
10.. Rodrigues CG, Rays J, Kanegae MY: Autops Case Rep, 2017; 7(3); 50-55
11.. Derber C, Elam K, Forbes BA, Bearman G: Can J Infect Dis Med Microbiol, 2011; 22(3); e17-e20
12.. Honnorat E, Seng P, Riberi A: BMC Res Notes, 2016; 9(1); 16-19
13.. Kumar S, Khaira J, Penigalapati D, Apurva A: J Glob Infect Dis, 2017; 9(2); 85
14.. Rafael AE, Keshavamurthy S, Sepulveda E: Texas Hear Inst J, 2014; 41(3); 324-26
15.. Sawant AC, Srivatsa SS, Castro LJ: Texas Hear Inst J, 2013; 40(1); 95-98
16.. Tokuyasu H, Fukushima T, Nakazaki H, Shimizu E: Intern Med, 2012; 51(9); 1133-38
17.. Storey A, Wilson A, McWilliams E: BMJ Case Rep, 2010; 2010; bcr0620103104
18.. Malek-Marín T, Arenas MD, Perdiguero M: Clin Nephrol, 2009; 72(5); 405-9
19.. Ahmed MS, Nistal C, Jayan R: Clin Nephrol, 2009; 71(3); 350-54
20.. Van Hal S, Stark D, Marriott D, Harkness J: J Med Microbiol, 2008; 57(4); 525-27
21.. Yang CH, Shih NC, Lu DCT: J Intern Med Taiwan, 2007; 18(4); 212-16
22.. Nanuashvili A, Kacharava G, Jashiashvili N: Euro Surveill, 2007; 12(5); E070524.2
23.. Ahn Y, Kim NH, Shin DH: J Korean Med Sci, 2004; 19(2); 291-93
24.. Martino P, Micozzi A, Venditti M: Rev Infect Dis, 1990; 12(2); 250-57
25.. Davis M, Gratten M, Ree GH: PNG Med J, 1982; 25(1); 7-11
26.. Lofgren RP, Nelson AE, Crossley KB: Am Heart J, 1981; 101(4); 502
27.. Bhattarai M, Papireddy M, Kulkarni S: J Hosp Med, 2016; 11(Suppl 1) http://www.shmabstracts.com/abstract/a-rare-case-of-complicated-achromobacter-xylosoxidans-endocarditis-and-its-successful-management
28.. lson DA, Hoeprich PD: West J Med, 1982; 136(2); 153-57
19 May 2022 : Case reportBilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936370
17 May 2022 : Case reportHigh-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.936651
13 May 2022 : Case reportA case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19
Am J Case Rep In Press; DOI: 10.12659/AJCR.936589
23 May 2022 : Case reportPharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus
Am J Case Rep In Press; DOI: 10.12659/AJCR.935148
23 May 2022 : Case reportA Case of Methicillin-Sensitive Staphylococcus aureus (MSSA) Prostate Abscess, Osteomyelitis, and Myositis ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.936704
23 May 2022 : Case reportAdalimumab Mitigates Lumbar Radiculopathy in a Case of Ankylosing Spondylitis
Am J Case Rep In Press; DOI: 10.12659/AJCR.936600
Most Viewed Current Articles
23 Feb 2022 : Case reportPenile Necrosis Associated with Local Intravenous Injection of Cocaine
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case reportMyocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...
Am J Case Rep 2022; 23:e934399
06 Dec 2021 : Case reportLipedema Can Be Treated Non-Surgically: A Report of 5 Cases
Am J Case Rep 2021; 22:e934406